When Is the Right Time to Consider DBS for Parkinson’s Disease?
In brief: The right time to consider a DBS evaluation is usually when Parkinson’s motor symptoms still respond to levodopa, but medication no longer provides consistent control throughout the day. Troublesome “off” periods, dyskinesia or disabling tremor are common reasons for referral. Patients do not necessarily need to wait until the disease becomes very advanced.
Deep brain stimulation is often described as a treatment of last resort. This description can be misleading.
DBS is not appropriate when symptoms remain well controlled with medication and quality of life is satisfactory. However, delaying evaluation until severe balance, cognitive or general health problems develop can also reduce the potential benefit or make surgery less suitable.
The aim is therefore not to perform surgery as early as possible. It is to identify the period when the symptoms most affecting the patient’s life are still likely to respond to stimulation and the patient remains medically and cognitively suitable for treatment.
What usually changes before DBS is considered?
During the earlier stages of Parkinson’s disease, medication often provides relatively smooth symptom control. As the disease progresses, the duration of benefit from each dose may become shorter or less predictable.
Patients may begin to experience:
Medication wearing off before the next dose
Longer or unpredictable “off” periods
Dyskinesia during peak medication effect
Difficult early mornings or nighttime immobility
Tremor that remains disabling despite treatment
Increasing difficulty planning work or social activities
Medication side effects that limit further dose adjustment
These changes do not automatically mean that DBS is required. They do suggest that treatment options, including device-assisted therapies, should be discussed.
Should DBS be delayed until Parkinson’s disease is advanced?
Not necessarily.
Current expert recommendations support referral for DBS evaluation when troublesome motor fluctuations, dyskinesia or medication-resistant tremor interfere with function or quality of life despite optimized medical management.
A referral can occur while medication adjustments continue. The purpose is to assess the patient before cognitive decline, frailty or levodopa-resistant balance problems become dominant.
DBS evaluation is not a commitment to surgery. The outcome may be:
Continuing medical treatment
Further medication adjustment
Reassessment at a later stage
Considering another device-assisted therapy
Proceeding with detailed surgical evaluation
In my discussions with patients, I explain that the appropriate time for an evaluation is often earlier than the appropriate time for an operation. Assessment provides information; it does not remove the patient’s choice.
Why does levodopa response matter?
DBS generally provides the greatest benefit for motor symptoms that improve with levodopa, including rigidity, slowness and many “off”-state difficulties.
If a patient still experiences a clear difference between the medication “off” and best “on” states, but the benefit does not last throughout the day, DBS may help make motor control more consistent.
Medication-resistant tremor can be an exception and may respond to DBS despite a limited levodopa response.
By contrast, symptoms that do not improve with levodopa—particularly severe balance problems, freezing, speech or swallowing impairment—are less likely to improve predictably with standard DBS.
What are the common signs that it may be time for an evaluation?
A DBS assessment may be reasonable when:
“Off” periods interfere with daily life
Dyskinesia is troublesome or disabling
Medication must be taken very frequently
Tremor remains uncontrolled despite appropriate treatment
Medication side effects prevent adequate symptom control
The patient has good periods but cannot maintain them throughout the day
Motor symptoms limit employment, independence or essential activities
The patient and family want to understand surgical and non-surgical advanced treatment options
The decision should focus on functional impact rather than a specific number of tablets or years since diagnosis.
Is there a minimum duration of Parkinson’s disease?
There is no single disease-duration rule that should be used in isolation.
A longer history can increase confidence in the diagnosis of idiopathic Parkinson’s disease. However, recent expert guidance places greater emphasis on diagnostic certainty, symptom profile, levodopa response and quality-of-life impact.
DBS should not be offered simply because a person has reached a particular year after diagnosis. Likewise, a suitable patient should not be denied evaluation only because they have not reached an arbitrary duration.
Can DBS be performed too early?
Yes. Surgery may be premature when:
Medication provides reliable symptom control
Motor fluctuations are mild and do not affect daily functioning
Medication options have not been adequately optimized
The diagnosis remains uncertain
The patient does not yet feel that the expected benefit justifies surgery and long-term device management
Research into earlier DBS suggests potential benefits in selected patients with emerging motor complications. This does not mean DBS should replace appropriate medical therapy in newly diagnosed or well-controlled Parkinson’s disease.
Can DBS evaluation be left too late?
Potentially. DBS becomes less suitable when the patient’s main disability is caused by symptoms that respond poorly to stimulation.
Concerns can include:
Significant dementia
Severe frailty
Uncontrolled psychiatric illness
Predominantly levodopa-resistant gait and balance problems
Frequent falls unrelated to medication “off” periods
Severe speech or swallowing dysfunction
Medical conditions creating unacceptable surgical risk
Age alone does not determine candidacy, but health, cognition and frailty can change over time. Early discussion allows patients and families to understand their options while more options remain available.
Does medication need to stop working completely?
No. In fact, continued levodopa responsiveness is usually a positive indicator.
A typical DBS candidate may experience excellent symptom control for part of the day but significant “off” periods or dyskinesia at other times. The problem is often inconsistency rather than complete medication failure.
Waiting until levodopa no longer produces meaningful motor improvement may reduce the symptoms that DBS can realistically treat.
What happens during a DBS timing assessment?
The team may evaluate:
Diagnostic certainty
The patient’s best “on” and worst “off” states
Duration and severity of motor fluctuations
Dyskinesia and tremor
Medication history and side effects
Cognition and psychiatric health
Gait, balance, speech and swallowing
General medical and surgical fitness
The patient’s treatment priorities and expectations
A formal levodopa challenge, brain MRI and neuropsychological testing may be arranged if the initial evaluation supports proceeding.
For more detail, see Who Is a Suitable Candidate for DBS Surgery?.
Can international patients be assessed before travelling?
An initial remote review may help determine whether a full DBS evaluation is reasonable. International patients can provide:
Neurology reports
Current medication schedule
A diary of “on” and “off” periods
Videos recorded in different medication states
Brain MRI files
Previous cognitive assessments, if available
A description of the symptoms that most affect daily life
Final candidacy generally requires an in-person movement-disorders, neuropsychological and neurosurgical assessment.
Frequently asked questions
Should I wait until medication stops helping?
No. DBS usually works best for motor symptoms that still respond to levodopa but are no longer controlled consistently throughout the day.
Does referral mean I have agreed to surgery?
No. Referral begins an assessment and education process. Surgery is only considered after the potential benefits, risks and alternatives have been reviewed.
Is severe tremor enough to consider DBS?
Disabling tremor that remains uncontrolled despite appropriate medication can justify an evaluation, even when other symptoms remain relatively well controlled.
Can someone be too young for DBS?
Age alone is not the deciding factor. Diagnostic certainty, symptom burden, medication response, cognition, general health and expectations are considered together.
Can someone be too old for DBS?
There is no universal upper age limit, but surgical risk, frailty and cognitive status become increasingly important. Assessment must be individualized.
Conclusion
The right time to consider DBS is not simply the earliest or latest stage of Parkinson’s disease. It is the period when troublesome motor symptoms interfere with quality of life despite optimized medication, still respond to levodopa and the patient remains an appropriate candidate for surgery and long-term follow-up.
A timely evaluation can clarify options without committing the patient to an operation.
Dr. Kaan Tugberk OzdemirNeurosurgeon – Izmir, Türkiye
This article is intended for general educational purposes and does not replace an individual neurological or neurosurgical assessment.
References
Comments